Related Experiment Video
Updated: Jul 9, 2026
11:59
Competitive Genomic Screens of Barcoded Yeast Libraries
Published on: August 11, 2011
Yeast genomics and drug target identification.
1Department of Molecular, Cellular, and Developmental Biology and the Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109-2216, USA.
Combinatorial Chemistry & High Throughput Screening
|November 30, 2007
Summary
Budding yeast genomics offers powerful tools for drug discovery. Researchers utilize yeast deletion mutants and microarray technologies for drug target identification and pathway analysis, advancing medicinal chemistry.
Area of Science:
- Genomics
- Medicinal Chemistry
- Drug Discovery
Background:
- Saccharomyces cerevisiae is a key model organism for genomic technology development.
- Extensive genomic resources in yeast are increasingly applied across scientific disciplines.
- Yeast genomics is becoming crucial for preliminary drug target identification.
Purpose of the Study:
- To review the applications of yeast genomics in identifying drug targets and pathways.
- To highlight the utility of yeast resources in drug development.
- To emphasize the synergy between model organism biology and medicinal chemistry.
Main Methods:
- Utilizing genome-wide yeast deletion mutant libraries for drug sensitivity/resistance screening.
- Employing microarray technologies for drug-induced transcriptional profiling.
- Applying protein-interaction traps for potential drug target discovery.
Main Results:
- Yeast genomics facilitates the identification of targeted genes and pathways for small molecules and drugs.
- Genome-wide mutant screening effectively identifies drug targets.
- Transcriptional profiling and interaction mapping reveal drug mechanisms.
Conclusions:
- Yeast genomics provides a robust platform for drug target identification and validation.
- The integration of yeast biology and medicinal chemistry accelerates drug development.
- This approach promises significant advancements for academic and pharmaceutical research.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:22Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:28Yeast Signaling
Yeasts are single-celled organisms, but unlike bacteria, they are eukaryotes (cells with a nucleus). Cell signaling in yeast is similar to signaling in other eukaryotic cells. A ligand, such as a protein or a small molecule released from a yeast cell, attaches to a receptor on the cell surface. The binding stimulates second-messenger kinases to activate or inactivate transcription factors that further regulate gene expression. Many of the yeast intracellular signaling cascades have similar...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...